1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Dr Joanne CHIU: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pembrolizumab, Lenvatinib and Chemotherapy After TKIs in NSCLC Pembrolizumab, Lenvatinib, Pemetrexed - Nsclc, EGFR Activating Mutation | Phase 2 | Unknown | Dr Joanne CHIU | 46 | 2021-10-05 | 2021-12-08 |
Carcinoma, Non-Small-Cell Lung (1)
Carboplatin (1) · Pemetrexed (1) · lenvatinib (1) · pembrolizumab (1)
Hong Kong (1)